|
|
||||||||||
|
J Am Coll Cardiol, 2005; 46:1799-1802, doi:10.1016/j.jacc.2005.07.053
(Published online 18 October 2005). © 2005 by the American College of Cardiology Foundation |
,*

,*
* Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College of Medicine, London, United Kingdom
Medizinische Klinik I, Universitätsklinikum, Bayerische Julius-Maximilians-Universität, Würzburg, Germany
Institute of Medical Immunology, Charité Campus Mitte, Berlin, Germany
Applied Cachexia Research, Department of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany
Manuscript received June 3, 2005; revised manuscript received July 1, 2005, accepted July 12, 2005.
* Reprint requests and correspondence: Dr. Thomas Thum, Julius-Maximilians University, Cardiology, Josef-Schneider Str. 2, Würzburg, Bavaria 97080, Germany. (Email: thum_t{at}klinik.uni-wuerzburg.de).
* Prof. Stefan Anker, National Heart and Lung Institute, Department of Clinical Cardiology, Dovehouse Street, London SW3 6LY, United Kingdom. (Email: s.anker{at}imperial.ac.uk).
Stem cell transplantation after myocardial infarction has been claimed to restore cardiac function, but the underlying mechanism remains unclear. A minority of transplanted cells become adherent in heart tissue and contribute to neovascularization, whereas many donor cells die from apoptosis. We propose that apoptosis of transplanted cells modulates local tissue reactions. Apoptotic cells impact on immune reactivity by down-regulating innate and adaptive immunity, deactivating macrophages and dendritic cells, and stimulating regulatory T cells. This leads to reduced scar formation, repressed myocardial apoptosis, and improved cardiac outcome.
| |||||||
This article has been cited by other articles:
![]() |
G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions Circulation, July 29, 2008; 118(5): 552 - 566. [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study Ann. Thorac. Surg., March 1, 2008; 85(3): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zeng, Q. Hu, X. Wang, A. Mansoor, J. Lee, J. Feygin, G. Zhang, P. Suntharalingam, S. Boozer, A. Mhashilkar, et al. Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling Circulation, April 10, 2007; 115(14): 1866 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Thum, D. Fraccarollo, S. Thum, M. Schultheiss, A. Daiber, P. Wenzel, T. Munzel, G. Ertl, and J. Bauersachs Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 748 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Dirnagl, J. Klehmet, J. S. Braun, H. Harms, C. Meisel, T. Ziemssen, K. Prass, and A. Meisel Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance Stroke, February 1, 2007; 38(2): 770 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lunde, S. Solheim, S. Aakhus, H. Arnesen, M. Abdelnoor, T. Egeland, K. Endresen, A. Ilebekk, A. Mangschau, J. G. Fjeld, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med., September 21, 2006; 355(12): 1199 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction Cardiovasc Res, September 1, 2006; 71(4): 744 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Torella, G. M. Ellison, and S. Dellegrottaglie Testing Regeneration of Human Myocardium Without Knowing the Identity and the Number of Effective Bone Marrow Cells Transplanted: Are the Results Meaningful? J. Am. Coll. Cardiol., July 18, 2006; 48(2): 417 - 417. [Full Text] [PDF] |
||||
![]() |
J. Leor, L. Rozen, A. Zuloff-Shani, M. S. Feinberg, Y. Amsalem, I. M. Barbash, E. Kachel, R. Holbova, Y. Mardor, D. Daniels, et al. Ex Vivo Activated Human Macrophages Improve Healing, Remodeling, and Function of the Infarcted Heart Circulation, July 4, 2006; 114(1_suppl): I-94 - I-100. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, Q. Hu, Y. Nakamura, J. Lee, G. Zhang, A. H.L. From, and J. Zhang The Role of the Sca-1+/CD31- Cardiac Progenitor Cell Population in Postinfarction Left Ventricular Remodeling Stem Cells, July 1, 2006; 24(7): 1779 - 1788. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |